Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Acute Lymphoblastic Leukemia With Unfavorable Features: A Phase III Group-wide Study

NCT00002812 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Acute Lymphoblastic Leukemia With Unfavorable Features: A Phase III Group-wide Study
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1996
Completion date
Not reported
Enrollment
2,078 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia